enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Why Is Exact Sciences Stock Trading Higher On Tuesday ... - AOL

   www.aol.com/finance/why-exact-sciences-stock...

   View More Analyst Ratings for EXAS. View the Latest Analyst Ratings "ACTIVE INVESTORS' SECRET WEAPON" Supercharge Your Stock Market Game with the #1 "news & everything else" trading tool: Benzinga ...

3. Exact Sciences (EXAS) in Focus: Stock Moves 11.6% Higher - AOL

   www.aol.com/news/exact-sciences-exas-focus-stock...

   Exact Sciences Corporation (EXAS) was a big mover last session, as the company saw its shares rise nearly 12% on the day. Exact Sciences Corporation (EXAS) was a big mover last session, as the ...

4. This Cathie Wood Growth Stock Could Soar by 93% ... - AOL

   www.aol.com/cathie-wood-growth-stock-could...

   To say that Exact Sciences (NASDAQ: EXAS) hasn't performed well on the stock market this year would be an understatement. Shares of the cancer-focused biotech are down by 41%. However, the ...

5. Exact Sciences (EXAS) Q3 2024 Earnings Call Transcript - AOL

   www.aol.com/finance/exact-sciences-exas-q3-2024...

   Exact Sciences issued a news release earlier this afternoon detailing our third-quarter financial results. ... *Stock Advisor returns as of November 4, 2024.

6. Exact Sciences (EXAS) Stock Sinks As Market Gains: What You ...

   www.aol.com/news/exact-sciences-exas-stock-sinks...

   In the latest trading session, Exact Sciences (EXAS) closed at $57.56, marking a -1.96% move from the previous day.

7. Here's Why Investors Should Hold Exact Sciences (EXAS) Stock

   www.aol.com/news/heres-why-investors-hold-exact...

   Growth in Exact Sciences' (EXAS) legacy Screening business is attributable to Cologuard volume growth and contributions from the PreventionGenetics, Biomatrica and Oncoguard Liver products.

8. Exact Sciences Stock Shows Every Sign Of Being ... - AOL

   www.aol.com/news/exact-sciences-stock-shows...

   The stock of Exact Sciences (NAS:EXAS, 30-year Financials) appears to be significantly undervalued, according to GuruFocus Value calculation.

9. Exact Sciences Reports 63% Reduction For Cologuard Testing in ...

   www.aol.com/news/exact-sciences-reports-63...

   Exact Sciences (EXAS) has pre-announced first quarter results, with total revenue up 114% year-over-year at $348 million, surpassing the Street estimate of $342.6 million.The company, which ...